CYP2W1 and neoplasm: Tumor-specific expression of CYP2W1 and its ability to activate multiple prodrugs to cytotoxic metabolites in mouse xenograft models of colorectal carcinoma (CRC) suggest that this enzyme may be an important target for CRC treatment [57, 60].